Introducing the Atropos Evidence™ Agent–seamlessly integrating RWE into the clinical workflow.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Planning
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Platform
          • GENEVA OS®
        • Evidence Generation Tools
          • ChatRWD®
          • Green Button®
          • Alexandria®
          • Forge®
          • Atropos Evidence™ Agent
        • Data
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
  • Contact Us
  • Login
Increase in Mortality and Allograft Rejection Post-Liver Transplant in a Cohort Between 50-90 Years Old

Increase in Mortality and Allograft Rejection Post-Liver Transplant in a Cohort Between 50-90 Years Old

by Julia Rudo | Jan 2, 2026 | Publications

An poster titled, “Increase in Mortality and Allograft Rejection Post-Liver Transplant in a Cohort Between 50-90 Years Old,” was presented at the American College of Gastroenterology’s (ACG) 2025 Annual Scientific Meeting & Postgraduate Course by authors...
Forbes: Atropos Health helps doctors, pharma companies and insurers figure out how patients react to treatments in the real-world

Forbes: Atropos Health helps doctors, pharma companies and insurers figure out how patients react to treatments in the real-world

by a9b1da23_admin | May 23, 2024 | News and Media

Katie Jennings of Forbes sat down with Dr. Brigham Hyde, CEO and co-Founder of Atropos Health to discuss the $33M Series B fundraise.See the full article here:...
Becker’s Hospital Review: Weight Loss Drugs and Surgery Complications: New study

Becker’s Hospital Review: Weight Loss Drugs and Surgery Complications: New study

by a9b1da23_admin | May 14, 2024 | News and Media

Paige Twenter of Becker’s Hospital Review covered a new study in Diabetes, Obesity, and Metabolism led by Dr. David Klonoff, a member of the Atropos Health Clinical Advisory Board.The study included an analysis of 130 million patient records. Researchers evaluated...
Becker’s Hospital Review: Weight Loss Drugs and Surgery Complications: New study

Beckers Hospital Review: Mayo Clinic Platform Partners with Atropos Health

by a9b1da23_admin | Nov 18, 2022 | News and Media

Giles Bruce of Becker’s Hospital Review covered Atropos new partnership with Mayo Clinic Platform to unlock rapid, on-demand clinical insights from Mayo Clinic data.Mayo Clinic Platform, the data analytics arm of Rochester, Minn.-based Mayo Clinic, is giving tech...
Mayo Clinic Platform and Atropos Health Partner to Bring Real-World Evidence to the Bedside

Mayo Clinic Platform and Atropos Health Partner to Bring Real-World Evidence to the Bedside

by a9b1da23_admin | Nov 11, 2022 | Press Release

Accelerating access to evidence-based care, on pace with clinical demandSee the ReleasePALO ALTO, Calif., Nov. 11, 2022 /PRNewswire/ — Atropos Health, leader in leveraging real-world evidence at the point of care, announces a collaboration with Mayo Clinic...
« Older Entries
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Planning

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Platform

GENEVA OS®

Evidence Generation Tools

ChatRWD®

Green Button®

Alexandria®

Forge®

Atropos Evidence™ Agent

Data

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}